Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternate endpoints for seizure measurement

J A Cramer1

  • 1Department of Neurology, Yale University School of Medicine, New Haven, Connecticut 06516, USA.

Advances in Neurology
|December 31, 1997
PubMed
Summary

Choosing the right seizure measurement is crucial for clinical trials. Tailoring these measures can provide valuable data to differentiate new epilepsy drugs and guide treatment choices.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral histories document community mobilisation to participate in decision-making regarding a hazardous waste thermal treatment facility.

Local environment·2024
Same author

Limitations of T2*-Gradient Recalled-Echo and Susceptibility-Weighted Imaging in Characterizing Chronic Subdural Hemorrhage in Infant Survivors of Abusive Head Trauma.

AJNR. American journal of neuroradiology·2016
Same author

Carotid body size on CTA: correlation with comorbidities.

Clinical radiology·2013
Same author

Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.

Acta neurologica Scandinavica·2013
Same author

Non-interventional surveillance study of adverse events in patients with epilepsy.

Acta neurologica Scandinavica·2010
Same author

Pregnancy registries in epilepsy: a consensus statement on health outcomes.

Neurology·2008

Area of Science:

  • Neurology
  • Clinical Trials
  • Pharmacology

Background:

  • Seizure measurement selection is critical in epilepsy clinical trials.
  • Trial needs evolve throughout the investigational agent development process.
  • Traditional outcome measures may not fully capture treatment efficacy.

Purpose of the Study:

  • To emphasize the importance of tailoring seizure measurements in clinical trials.
  • To highlight the potential of nontraditional outcome measures.
  • To inform drug selection for various seizure disorders.

Main Methods:

  • Review of current practices in seizure measurement selection for clinical trials.
  • Analysis of how evolving trial needs impact outcome measure choices.
  • Consideration of nontraditional outcome measures for drug differentiation.

Main Results:

  • Tailored seizure measurements provide valuable data for drug development.
  • Nontraditional outcome measures can differentiate investigational agents.
  • Effectiveness studies benefit from robust seizure data for clinical decision-making.

Conclusions:

  • Seizure measurement strategies must adapt to clinical trial phases.
  • Adoption of diverse outcome measures enhances drug differentiation.
  • Informed drug selection for seizure disorders relies on comprehensive trial data.

Related Experiment Videos